Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

How a virtual assistant can help boost medication adherence

By Brian Buntz | August 17, 2022

UBC logoMedication adherence is often low for people who are transitioning out of a hospital setting. Such patients may have received a starter dose during a visit to an emergency room or an overnight hospital stay but fail to pick up medication in a pharmacy after that.

“It’s a key pain point. There can be as much as a 50% drop off,” said Ron Lacy, VP Of products and innovation at UBC.

To optimize the medication adherence related to new prescriptions of an approved product, UBC worked with health IT firm DrFirst. In addition, the companies worked together to use software for patient support services related to the drug.

DrFirst has developed an electronic prescription writing platform connected to leading EMR systems.

UBC initially planned to partner directly with the healthcare system to address the issue of low medication adherence. In the early days of the pandemic, the company had a plan to send text messages to patients transitioning out of a hospital environment. “But the focus and energy at that time were all about responding to the pandemic so that we couldn’t move that forward,” Lacy said.

The company then changed gears, deciding to use DrFirst’s e-prescribing technology to notify patients. “We have had a relationship with DrFirst for different services over the years. We’ve used them before on clinical trial messaging,” Lacy noted. “That’s kind of where the idea came from. We wondered, ‘Can I do something similar to what we’ve done with a clinical trial at a patient-access site?'”

The companies worked together to create a system that would create a call-to-action for patients to opt into a virtual assistant that includes messaging and patient support.

Patients who enrolled in the system and used the virtual assistant received a series of programmed conversations for two months. The virtual discussions were designed to educate, motivate and remind patients of important events, including prescription pick-ups.

“The virtual assistant involves a conversation with a scripted bot,” Lacy said. “It’s not an AI bot.”

Whereas the banking industry, for instance, uses AI bots that optimize answers based on what users type, a scripted bot, in this example, provides a scripted conversation that gives users a choice of how to engage with it.

“So, for example, one of the conversations we focused on was patient education around this disease state,” Lacy said.

The virtual assistant also helps patients navigate educational materials related to copays and other topics. “Based on how the patient answered, we can guide them through those educational materials,” Lacy said.

The system proved successful at improving patient adherence. A quarter of patients indicated they picked up their medication after receiving virtual assistant reminders. A total of 17% of patients responded directly to the refill reminder.

In addition, 95% of patients indicated that they found the virtual assistant’s updates and education programs helpful.

The feedback has been “overwhelmingly consistent over the 20,000-plus conversations we’ve had,” Lacy said.

About The Author

Brian Buntz

The pharma and biotech editor of WTWH Media, Brian is a veteran journalist with more than 15 years of experience covering an array of life science topics, including clinical trials, drug discovery and development and medical devices. Before coming to WTWH, he served as content director focused on connected devices at Informa. In addition, Brian covered the medical device sector for 10 years at UBM. At Qmed, he overhauled the brand’s news coverage and helped to grow the site’s traffic volume dramatically. He had previously held managing editor roles on two of the company’s medical device technology publications. Connect with him on LinkedIn or email at [email protected].

Tell Us What You Think! Cancel reply

Related Articles Read More >

Cardinal Health logo
Cardinal Health to build pharma distribution plant in Indianapolis
Nymi Logo_2022 (1)
Nymi, Caliber partner on passwordless authentication for pharma manufacturing
Genentech roche
Roche, Genentech to build $700M drug manufacturing plant in North Carolina
These are the logos of Otsuka Medical and ICU Medical.
ICU Medical, Otsuka Pharmaceutical Factory launch joint IV supply chain venture
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2026 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE